Cite
Maher M, Diesch J, Le Pannérer MM, et al. Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18. Sci Rep. 2021;11(1):21145doi: 10.1038/s41598-021-00623-w.
Maher, M., Diesch, J., Le Pannérer, M. M., Cabezón, M., Mallo, M., Vergara, S., Méndez López, A., Mesa Tudel, A., Solé, F., Sorigue, M., Zamora, L., Granada, I., & Buschbeck, M. (2021). Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18. Scientific reports, 11(1), 21145. https://doi.org/10.1038/s41598-021-00623-w
Maher, Michael, et al. "Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18." Scientific reports vol. 11,1 (2021): 21145. doi: https://doi.org/10.1038/s41598-021-00623-w
Maher M, Diesch J, Le Pannérer MM, Cabezón M, Mallo M, Vergara S, Méndez López A, Mesa Tudel A, Solé F, Sorigue M, Zamora L, Granada I, Buschbeck M. Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18. Sci Rep. 2021 Oct 27;11(1):21145. doi: 10.1038/s41598-021-00623-w. PMID: 34707142; PMCID: PMC8551338.
Copy
Download .nbib